These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9858330)

  • 1. The influence of race on the efficacy of curative radiation therapy for carcinoma of the prostate.
    Hart KB; Porter AT; Shamsa F; Chuba PJ; Pontes JE; Forman JD
    Semin Urol Oncol; 1998 Nov; 16(4):227-31. PubMed ID: 9858330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy.
    Hart KB; Wood DP; Tekyi-Mensah S; Porter AT; Pontes JE; Forman JD
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1235-8. PubMed ID: 10613318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research.
    Johnstone PA; Kane CJ; Sun L; Wu H; Moul JW; McLeod DG; Martin DD; Kusuda L; Lance R; Douglas R; Donahue T; Beat MG; Foley J; Baldwin D; Soderdahl D; Do J; Amling CL
    Radiology; 2002 Nov; 225(2):420-6. PubMed ID: 12409575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of race on freedom from prostate-specific antigen failure in prostate cancer patients treated with definitive radiation therapy.
    Young CD; Lewis P; Weinberg V; Lee TT; Coleman CW; Roach M
    Semin Urol Oncol; 2000 May; 18(2):121-6. PubMed ID: 10875452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males.
    Iselin CE; Box JW; Vollmer RT; Layfield LJ; Robertson JE; Paulson DF
    Cancer; 1998 Dec; 83(11):2353-60. PubMed ID: 9840535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should African-American men be tested for prostate carcinoma at an earlier age than white men?
    Powell IJ; Banerjee M; Sakr W; Grignon D; Wood DP; Novallo M; Pontes E
    Cancer; 1999 Jan; 85(2):472-7. PubMed ID: 10023717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
    Powell IJ; Banerjee M; Novallo M; Sakr W; Grignon D; Wood DP; Pontes JE
    Urology; 2000 Feb; 55(2):246-51. PubMed ID: 10688088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparity and survival outcomes between African-American and Caucasian American men with penile cancer.
    Ritch CR; Soodana-Prakash N; Pavan N; Balise RR; Velasquez MC; Alameddine M; Adamu DY; Punnen S; Parekh DJ; Gonzalgo ML
    BJU Int; 2018 May; 121(5):758-763. PubMed ID: 29281853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis.
    Powell IJ; Dey J; Dudley A; Pontes JE; Cher ML; Sakr W; Grignon DJ; Wood DP
    Urology; 2002 Jun; 59(6):907-12. PubMed ID: 12031379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of circulating prostate cancer cells in African American males adversely affects survival.
    Bianco FJ; Powell IJ; Cher ML; Wood DP
    Urol Oncol; 2002; 7(4):147-52. PubMed ID: 12474530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Sun LL; Moul JW; Freedland SJ
    Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):87-93. PubMed ID: 19918263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
    Bianco FJ; Wood DP; Grignon DJ; Sakr WA; Pontes JE; Powell IJ
    J Urol; 2002 Aug; 168(2):479-82. PubMed ID: 12131292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting.
    Howard LE; Zhang J; Fishbane N; Hoedt AM; Klaassen Z; Spratt DE; Vidal AC; Lin D; Hitchins MP; You S; Freeman MR; Yamoah K; Davicioni E; Freedland SJ
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):419-428. PubMed ID: 31844180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.
    Optenberg SA; Thompson IM; Friedrichs P; Wojcik B; Stein CR; Kramer B
    JAMA; 1995 Nov 22-29; 274(20):1599-605. PubMed ID: 7474244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation.
    Zagars GK; Pollack A; Pettaway CA
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):517-23. PubMed ID: 9806509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration.
    Wood HM; Reuther AM; Gilligan TD; Kupelian PA; Modlin CS; Klein EA
    J Urol; 2007 Oct; 178(4 Pt 1):1271-6. PubMed ID: 17698101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapy.
    Rosser CJ; Kuban DA; Levy LB; Pettaway CA; Chichakli R; Kamat AM; Sanchez-Ortiz RF; Pisters LL
    J Urol; 2003 Nov; 170(5):1856-9. PubMed ID: 14532792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of race on biochemical control in patients with localized prostate cancer treated with permanent brachytherapy: multivariate and matched-pair analyses.
    Lee LN; Barnswell C; Torre T; Fearn P; Kattan M; Potters L
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):282-9. PubMed ID: 12023131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of location and multifocality of positive surgical margins on disease-free survival following radical prostatectomy: a comparison between African-American and white men.
    Shekarriz B; Tiguert R; Upadhyay J; Gheiler E; Powell IJ; Pontes JE; Grignon DJ; Sakr W; Wood DP
    Urology; 2000 Jun; 55(6):899-903. PubMed ID: 10840105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.